BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23675530)

  • 1. Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation.
    Chen X; Yang G; Song JH; Xu H; Li D; Goldsmith J; Zeng H; Parsons-Wingerter PA; Reinecker HC; Kelly CP
    PLoS One; 2013; 8(5):e64227. PubMed ID: 23675530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice.
    Zhou H; Zhang HJ; Guan L; Zhang YN; Li Y; Sun MJ
    Mol Med Rep; 2018 Dec; 18(6):5652-5662. PubMed ID: 30387820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis.
    Chen X; Kokkotou EG; Mustafa N; Bhaskar KR; Sougioultzis S; O'Brien M; Pothoulakis C; Kelly CP
    J Biol Chem; 2006 Aug; 281(34):24449-54. PubMed ID: 16816386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.
    Chen X; Fruehauf J; Goldsmith JD; Xu H; Katchar KK; Koon HW; Zhao D; Kokkotou EG; Pothoulakis C; Kelly CP
    Gastroenterology; 2009 Sep; 137(3):914-23. PubMed ID: 19482027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Probiotic Effects of the
    Lee JE; Lee E
    J Microbiol Biotechnol; 2022 Jul; 32(7):877-884. PubMed ID: 35791078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis.
    Wang XL; Zhao J; Qin L; Qiao M
    Braz J Med Biol Res; 2016; 49(5):e4738. PubMed ID: 27074165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
    Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
    Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition.
    Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J
    J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice.
    Dong JP; Zheng Y; Wu T; He Q; Teng GG; Wang HH
    Chin Med J (Engl); 2019 Aug; 132(16):1951-1958. PubMed ID: 31335471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
    Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor receptor-2 inhibition in experimental murine colitis.
    Knod L; Donovan EC; Chernoguz A; Crawford KM; Dusing MR; Frischer JS
    J Surg Res; 2013 Sep; 184(1):101-7. PubMed ID: 23688787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of vascular endothelial growth factor signaling by miR-200b.
    Choi YC; Yoon S; Jeong Y; Yoon J; Baek K
    Mol Cells; 2011 Jul; 32(1):77-82. PubMed ID: 21544626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.
    Spirli C; Okolicsanyi S; Fiorotto R; Fabris L; Cadamuro M; Lecchi S; Tian X; Somlo S; Strazzabosco M
    Gastroenterology; 2010 Jan; 138(1):360-371.e7. PubMed ID: 19766642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly-γ-glutamic acid attenuates angiogenesis and inflammation in experimental colitis.
    Davaatseren M; Hwang JT; Park JH; Kim MS; Wang S; Sung MJ
    Mediators Inflamm; 2013; 2013():982383. PubMed ID: 23766568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
    Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP
    Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurotensin-HIF-1α-VEGFα axis orchestrates hypoxia, colonic inflammation, and intestinal angiogenesis.
    Bakirtzi K; West G; Fiocchi C; Law IK; Iliopoulos D; Pothoulakis C
    Am J Pathol; 2014 Dec; 184(12):3405-14. PubMed ID: 25307345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling.
    Wang QQ; Zhou SJ; Meng ZX; Wang J; Chen R; Lv L; Li CJ; Yu DM; Yu P
    Mol Med Rep; 2015 Mar; 11(3):2167-72. PubMed ID: 25405610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.